Simplifying Oncology NGS Implementation with an IVD Test: Verification, Informatics, Reporting, and Reimbursement

Join us to learn how an IVD approach can support a more streamlined path from implementation planning to daily operations.

Pathologist Perspectives on PD-L1 CPS Scoring in Challenging Cases.

Implementation of a large liquid biopsy genomic profiling assay in a decentralized setting

In this webinar, Dr. Gang Zheng MD, PhD, will share experience from the Mayo Clinic laboratory, how the lab approaches liquid biopsy and recent implementation data of a liquid biopsy assay to enable comprehensive genomic profiling (CGP).

Liquid Biopsy in Lung and Breast Cancer: Real World Tumour Profiling and Clinical Insights

Liquid biopsy is increasingly being adopted to support tumour profiling across cancer pathways, particularly where tissue is limited or results are needed quickly.

AML Complexity Uncovered: A Unified Whole Genome and Informatics Approach for High Resolution Disease Understanding

Standard-of-care (SOC) genomic testing in acute myeloid leukemia (AML) has historically resulted in fragmented, incomplete genomic profiles that mask clinically significant biology.

How to increase efficiency in Routine Oncology NGS Workflows

In this webinar, you’ll see real time-and-motion data comparing two NGS workflows (amplicon based Oncomine Dx Express Test* and hybrid capture based NGS workflow) for routine precision oncology,

The Future of Pathology – Digital Innovation, Enterprise Imaging and AI

Pathology is changing. And not just a little—it’s undergoing a transformation that will define the future of healthcare.

Advancing biomarker detection in lymphoid malignancies: Insights from leading scientists

Watch our illuminating on-demand webinar titled "Advancing biomarker detection in lymphoid malignancies: Insights from leading scientists," featuring two of the foremost authorities in haemato-oncology.

Setting a new standard: discover next-day CGP with Oncomine Comprehensive Assay Plus on the Genexus System

Rapid comprehensive genomic profiling (CGP) is crucial for gaining important insights when timely results matter.

Enable Comprehensive Genomic Profiling with Product Updates on TruSight™ Oncology 500 v2

TruSight™ Oncology 500 v2 (TSO500v2) is an updated next-generation sequencing (NGS) assay designed to enable laboratories with in-house comprehensive genomic profiling (CGP) from formalin-fixed, paraffin-embedded (FFPE) tissue samples.